Patent details

Basic Information

Publication number:

EP0822199

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP971175146

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

N-terminally monopegylated polypeptides and process for their preparation.

French Title of Invention:

Polypeptides monopegylés à l'extrémité N-terminale, et procédé pour leur préparation

German Title of Invention:

N-terminal modifizierte Polypeptide, und Herstellungsprozess

SPC Number:

Dates

Filing date:

08/02/1995

Grant date:

22/09/2004

EP Publication Date:

22/09/2004

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/02/1998

EP B1 Publication Date:

22/09/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

08/02/2015

Renunciation date:

Revocation date:

15/06/2010

Annulment date:

Owner

From:

08/02/1995

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

22/09/2004

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Gabriel Nancy E.

Address:

United States (US)

2

Name:

Farrar Christine E.

Address:

United States (US)

3

Name:

Deprince Randolph B.

Address:

United States (US)

4

Name:

Kinstler Olaf B.

Address:

United States (US)

Priority

Priority Number:

321510

Priority Date:

12/10/1994

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 14/53;

Filing date	Document type	Number of pages